Teva to Present Findings on Short-Acting Beta Agonist (SABA) Use in Asthma Patients and the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder to Help Inform Treatment Decisions at American Thoracic Society 2022 Annual Meeting
Late-breaking abstract will highlight the application of independent expert consensus thresholds for SABA use to an asthma patient cohort whose daily SABA use was reliably recorded via a digital platform TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS ...